Hepatic Vasculopathy and Regenerative Responses of the Liver in Fatal Cases of COVID-19

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved..

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects the nasopharynx and lungs and causes coronavirus disease-2019 (COVID-19). It may impact the heart, brain, kidney, and liver.1 Although functional impairment of the liver has been correlated with worse clinical outcomes, little is known about the pathophysiology of hepatic injury and repair in COVID-19.2,3 Histologic evaluation has been limited to small numbers of COVID-19 cases with no control subjects2,4 and demonstrated largely heterogeneous patterns of pathology.2,3.

Errataetall:

CommentIn: Clin Gastroenterol Hepatol. 2021 Jul;19(7):1508-1509. - PMID 33581360

Media Type:

Electronic Article

Year of Publication:

2021

Contained In:

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association - Vol. 19, No. 8 (2021), p. 1726-1729.e3

Language:

English

Contributors:

Kaltschmidt, Barbara
Fitzek, Antonia D E
Schaedler, Julia
Förster, Christine
Kaltschmidt, Christian
Hansen, Torsten
Steinfurth, Fabian
Windmöller, Beatrice A
Pilger, Christian
Kong, Cihang
Singh, Kashika
Nierhaus, Axel
Wichmann, Dominic
Sperhake, Jan
Püschel, Klaus
Huser, Thomas
Krüger, Martin
Robson, Simon C
Wilkens, Ludwig
Schulte Am Esch, Jan

Links:

Volltext

Keywords:

Journal Article
Research Support, Non-U.S. Gov't

Notes:

Date Revised 22.07.2021

published: Print-Electronic

CommentIn: Clin Gastroenterol Hepatol. 2021 Jul;19(7):1508-1509. - PMID 33581360

Citation Status In-Process

Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Physical Description:

Online-Ressource

doi:

10.1016/j.cgh.2021.01.044

PMID:

33516952

PPN (Catalogue-ID):

NLM321823699